Skip to main content

Peer Review reports

From: Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway

Original Submission
1 Jun 2016 Submitted Original manuscript
22 Sep 2016 Reviewed Reviewer Report - Shanmugam Panneer Selvam
28 Sep 2016 Reviewed Reviewer Report - Le Meng
25 Oct 2016 Author responded Author comments - Xue Wu
Resubmission - Version 2
25 Oct 2016 Submitted Manuscript version 2
1 Nov 2016 Reviewed Reviewer Report - Le Meng
13 Feb 2017 Author responded Author comments - Xue Wu
Resubmission - Version 3
13 Feb 2017 Submitted Manuscript version 3
Publishing
15 Feb 2017 Editorially accepted
21 Feb 2017 Article published 10.1186/s12885-017-3145-4

You can find further information about peer review here.

Back to article page